» Articles » PMID: 20067707

Strategies to Prolong the Intravaginal Residence Time of Drug Delivery Systems

Overview
Specialties Pharmacology
Pharmacy
Date 2010 Jan 14
PMID 20067707
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The vagina has been studied as a favorable site for local and systemic delivery of drugs for female-related conditions. There are a large number of vaginal medications on the market and most of them require frequent application due to their short vaginal residence time. A prolonged vaginal residence time of formulations is therefore a key parameter for improved therapeutic efficacy. Promising approaches to prolong the residence time base on mucoadhesion, in- situ sol-gel transition and mechanical fixation. Mucoadhesive drug delivery systems can be tailored to adhere to the vaginal tissue. In-situ gelling systems offer the advantage of increased viscosity in vaginal cavity and consequently reduce outflow from the vagina. Mechanical fixation needs specially shaped drug delivery systems and reduce the frequency of administration significantly. Within this review an overview on these different strategies and systems is provided. Furthermore, the techniques to evaluate the potential of these systems for prolonged vaginal residence time are described.

Citing Articles

Novel Drug Delivery Approaches for the Localized Treatment of Cervical Cancer.

Saha I, Halder J, Rajwar T, Mahanty R, Pradhan D, Dash P AAPS PharmSciTech. 2024; 25(4):85.

PMID: 38605158 DOI: 10.1208/s12249-024-02801-1.


Vaginal Sheets with Essential Oil for the Treatment of Bacterial Vaginosis: Design, Characterization and Evaluation of Efficacy and Safety.

Tomas M, Sousa L, Oliveira A, Gomes C, Palmeira-de-Oliveira A, Cavaleiro C Gels. 2023; 9(4).

PMID: 37102907 PMC: 10137747. DOI: 10.3390/gels9040293.


Insight into the ecology of vaginal bacteria through integrative analyses of metagenomic and metatranscriptomic data.

France M, Fu L, Rutt L, Yang H, Humphrys M, Narina S Genome Biol. 2022; 23(1):66.

PMID: 35232471 PMC: 8886902. DOI: 10.1186/s13059-022-02635-9.


Recent Advances in the Excipients Used in Modified Release Vaginal Formulations.

Dedeloudi A, Siamidi A, Pavlou P, Vlachou M Materials (Basel). 2022; 15(1).

PMID: 35009472 PMC: 8745980. DOI: 10.3390/ma15010327.


Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract.

Nader-Macias M, De Gregorio P, Silva J Pharmacol Res Perspect. 2021; 9(5):e00787.

PMID: 34609059 PMC: 8491456. DOI: 10.1002/prp2.787.